Publications scientifiques Bordet

Publications scientifiques Bordet

Clinical Behavior of Breast Cancer in Young <i>BRCA</i> Carriers and Prediagnostic Awareness of Germline <i>BRCA</i> Status.

Lambertini M, Blondeaux E, Tomasello LM, Agostinetto E, Hamy AS, Kim HJ, Franzoi MA, Bernstein-Molho R, Hilbers F, Pogoda K, Wildiers H, Bajpai J, Ignatiadis M, Moore HCF, Partridge AH, Phillips KA, Toss A, Rousset-Jablonski C, Criscitiello C, Renaud T, Ferrari A, Paluch-Shimon S, Fruscio R, Cui W, Wong SM, Vernieri C, Ruddy KJ, Dieci MV, Matikas A, Rozenblit M, Villarreal-Garza C, De Marchis L, Puglisi F, Rodriguez-Wallberg KA, Duhoux FP, Livraghi L, Bruzzone M, Boni L, Balmaña J

Clinical Behavior of Breast Cancer in Young <i>BRCA</i> Carriers and Prediagnostic Awareness of Germline <i>BRCA</i> Status.

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Metoikidou C, Karnaukhov V, Boeckx B, Timperi E, Bonté PE, Wang L, Espenel M, Albaud B, Loirat D, Wang X, Sotiriou C, Aftimos P, Punie K, Wildiers H, Labroska V, Wang MW, Waterfall JJ, Piccart-Gebhart M, Mora T, Walczak A, Lantz O, Buisseret L, Lambrechts D, Amigorena S, Romano E

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Metoikidou C, Karnaukhov V, Boeckx B, Timperi E, Bonté PE, Wang L, Espenel M, Albaud B, Loirat D, Wang X, Sotiriou C, Aftimos P, Punie K, Wildiers H, Labroska V, Wang MW, Waterfall JJ, Piccart-Gebhart M, Mora T, Walczak A, Lantz O, Buisseret L, Lambrechts D, Amigorena S, Romano E

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Metoikidou C, Karnaukhov V, Boeckx B, Timperi E, Bonté PE, Wang L, Espenel M, Albaud B, Loirat D, Wang X, Sotiriou C, Aftimos P, Punie K, Wildiers H, Labroska V, Wang MW, Waterfall JJ, Piccart-Gebhart M, Mora T, Walczak A, Lantz O, Buisseret L, Lambrechts D, Amigorena S, Romano E

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Metoikidou C, Karnaukhov V, Boeckx B, Timperi E, Bonté PE, Wang L, Espenel M, Albaud B, Loirat D, Wang X, Sotiriou C, Aftimos P, Punie K, Wildiers H, Labroska V, Wang MW, Waterfall JJ, Piccart-Gebhart M, Mora T, Walczak A, Lantz O, Buisseret L, Lambrechts D, Amigorena S, Romano E

Continuous replenishment of the dysfunctional CD8 T cell axis is associated with response to chemoimmunotherapy in advanced breast cancer.

Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.

Roux A, Hervouet L, Stefano FD, French DP, Giordano L, Ritchie D, Bugat MR, Keatley D, Cholerton R, McWilliams L, Rossi PG, Balleyguier C, Guindy M, Gilbert FJ, Burrion JB, Roman M, Vissac-Sabatier C, Couch D, Delaloge S, Montgolfier S

Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.

Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial.

Caluwé A, Bellal S, Cao K, Peignaux K, Remouchamps V, Baten A, Longton E, Bessieres I, Vu-Bezin J, Kirova Y, Gestel DV, Desmoulins I, Ignatiadis M, Romano E, Buisseret L, Piccart M, Vandekerkhove C, Gulyban A, Poortmans P

Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial.
Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasmus

Publications scientifiques d'Erasmus
Huderf hospital

Hôpital pédiatrique Reine Fabiola

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Publications scientifiques de l'Hôpital pour enfants Reine Fabiola
Bordet hospital

Institut Jules Bordet

Consultez toutes les publications scientifiques de Jules Bordet

Publications scientifiques de Jules Bordet